Immunotherapeutic Approaches to Head and Neck Squamous Cell Carcinoma: Current Clinical Practice and Future Directions - Top-Institutions - MDSpire

Immunotherapy Strategies for Head and Neck Squamous Cell Carcinoma: Present Practices and Future Perspectives

  • By

  • Carol R. Bradford

  • Sreeram M. P.

  • Karthik N. Rao

  • Orlando Guntinas-Lichius

  • Nabil Saba

  • Alfio Ferlito

  • July 9, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Immunotherapy

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Immunotherapy

  • #3

    Emory University
    Emory University

    Atlanta, Georgia

    Key Differentiators

    • Oncology

  • #4

    Winship Cancer Institute
    Winship Cancer Institute

    Atlanta, Georgia

    Key Differentiators

    • Oncology

  • #5

    University of Chicago Medicine
    University of Chicago Medicine

    Chicago, Illinois

    Key Differentiators

    • Oncology

Original Source(s)

Immunotherapeutic Approaches to Head and Neck Squamous Cell Carcinoma: Current Clinical Practice and Future Directions

  • by Carol R. Bradford, Sreeram M. P., Karthik N. Rao, Orlando Guntinas-Lichius, Nabil Saba, Alfio Ferlito

  • July 9, 2026

Related Content

The Power List 2026 is Live

We celebrate 60 inspiring individuals helping turn pharma’s boldest ideas into reality

  • July 21, 2026

  • 1 min
Prognostic value of existing scoring systems for early mortality in phase I immunotherapy trials: a head-to-head real-world cohort study

Treatment patterns and survival outcomes in elderly patients with intrahepatic cholangiocarcinoma: NCDB analysis